Assessment of exposure to butadiene in the process industry

Toxicology. 1996 Oct 28;113(1-3):77-83. doi: 10.1016/0300-483x(96)03430-0.

Abstract

Occupational exposure levels to 1,3-butadiene (BD) are variable but generally below 1 ppm in the European process industry. A preliminary analysis showed that hemoglobin adduct levels of butadiene monoxide (BMO) were increased among the worker groups with higher potential exposure to BD (process work, bomb voiding, repair duties) than among less exposed workers in maintenance and laboratory or control persons. In the same workers no exposure related effects were seen in the cytogenetic parameters studied, i.e. chromosomal aberrations, sister chromatid exchanges or micronuclei in peripheral blood lymphocytes. However, the glutathione-S-transferase polymorphism in the T1 gene might play a role in determining interindividual sensitivity to BD-induced chromosomal aberrations. Chromosomal aberrations (gaps excluded) were significantly (P < 0.05) increased among the workers lacking the GSTT1 gene as compared to the BD workers with the gene, while the other polymorphic GSTM1 gene showed no association with the cytogenetic parameters. More work needs to be done to study the adducts by other active BD metabolites than BMO and the role of the genetic polymorphisms controlling the variability of individual responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butadienes / toxicity*
  • Carcinogens / toxicity*
  • Chromosome Aberrations
  • Environmental Monitoring
  • Genotype
  • Glutathione Transferase / genetics
  • Hemoglobins / metabolism
  • Humans
  • Occupational Exposure*

Substances

  • Butadienes
  • Carcinogens
  • Hemoglobins
  • Glutathione Transferase
  • 1,3-butadiene